Global and United States Pharmaceutical CDMO Services Market Report & Forecast 2023-2028

Report ID: 1823025 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pharmaceutical CDMO Services Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Pharmaceutical CDMO Services Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Pharmaceutical CDMO Services Market Size for the Year 2017-2028
        1.2.2 Global Pharmaceutical CDMO Services Market Size for the Year 2017-2028
    1.3 Pharmaceutical CDMO Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Pharmaceutical CDMO Services in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Pharmaceutical CDMO Services Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Pharmaceutical CDMO Services Market Dynamics
        1.4.1 Pharmaceutical CDMO Services Industry Trends
        1.4.2 Pharmaceutical CDMO Services Market Drivers
        1.4.3 Pharmaceutical CDMO Services Market Challenges
        1.4.4 Pharmaceutical CDMO Services Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Pharmaceutical CDMO Services by Type
    2.1 Pharmaceutical CDMO Services Market Segment by Type
        2.1.1 Drug Substance Development and Manufacturing
        2.1.2 Specialized Services
        2.1.3 Lab-based Services
    2.2 Global Pharmaceutical CDMO Services Market Size by Type (2017, 2022 & 2028)
    2.3 Global Pharmaceutical CDMO Services Market Size by Type (2017-2028)
    2.4 United States Pharmaceutical CDMO Services Market Size by Type (2017, 2022 & 2028)
    2.5 United States Pharmaceutical CDMO Services Market Size by Type (2017-2028)
3 Pharmaceutical CDMO Services by Application
    3.1 Pharmaceutical CDMO Services Market Segment by Application
        3.1.1 Innovative Medicine
        3.1.2 Patented Drug
        3.1.3 Patent Expired Drug
    3.2 Global Pharmaceutical CDMO Services Market Size by Application (2017, 2022 & 2028)
    3.3 Global Pharmaceutical CDMO Services Market Size by Application (2017-2028)
    3.4 United States Pharmaceutical CDMO Services Market Size by Application (2017, 2022 & 2028)
    3.5 United States Pharmaceutical CDMO Services Market Size by Application (2017-2028)
4 Global Pharmaceutical CDMO Services Competitor Landscape by Company
    4.1 Global Pharmaceutical CDMO Services Market Size by Company
        4.1.1 Top Global Pharmaceutical CDMO Services Companies Ranked by Revenue (2021)
        4.1.2 Global Pharmaceutical CDMO Services Revenue by Player (2017-2022)
    4.2 Global Pharmaceutical CDMO Services Concentration Ratio (CR)
        4.2.1 Pharmaceutical CDMO Services Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Pharmaceutical CDMO Services in 2021
        4.2.3 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Pharmaceutical CDMO Services Headquarters, Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Pharmaceutical CDMO Services Headquarters and Area Served
        4.3.2 Global Pharmaceutical CDMO Services Companies Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Pharmaceutical CDMO Services Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Pharmaceutical CDMO Services Market Size by Company
        4.5.1 Top Pharmaceutical CDMO Services Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Pharmaceutical CDMO Services Revenue by Players (2020, 2021 & 2022)
5 Global Pharmaceutical CDMO Services Market Size by Region
    5.1 Global Pharmaceutical CDMO Services Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Pharmaceutical CDMO Services Market Size by Region (2017-2028)
        5.2.1 Global Pharmaceutical CDMO Services Market Size by Region: 2017-2022
        5.2.2 Global Pharmaceutical CDMO Services Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Pharmaceutical CDMO Services Market Size YoY Growth 2017-2028
        6.1.2 North America Pharmaceutical CDMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Pharmaceutical CDMO Services Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Pharmaceutical CDMO Services Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Pharmaceutical CDMO Services Market Size YoY Growth 2017-2028
        6.3.2 Europe Pharmaceutical CDMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Pharmaceutical CDMO Services Market Size YoY Growth 2017-2028
        6.4.2 Latin America Pharmaceutical CDMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Pharmaceutical CDMO Services Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Pharmaceutical CDMO Services Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Recipharm AB
        7.1.1 Recipharm AB Company Details
        7.1.2 Recipharm AB Business Overview
        7.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction
        7.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.1.5 Recipharm AB Recent Development
    7.2 AMRI Global
        7.2.1 AMRI Global Company Details
        7.2.2 AMRI Global Business Overview
        7.2.3 AMRI Global Pharmaceutical CDMO Services Introduction
        7.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.2.5 AMRI Global Recent Development
    7.3 Patheon N.V.
        7.3.1 Patheon N.V. Company Details
        7.3.2 Patheon N.V. Business Overview
        7.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction
        7.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.3.5 Patheon N.V. Recent Development
    7.4 Aenova Group
        7.4.1 Aenova Group Company Details
        7.4.2 Aenova Group Business Overview
        7.4.3 Aenova Group Pharmaceutical CDMO Services Introduction
        7.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.4.5 Aenova Group Recent Development
    7.5 Catalent, Inc.
        7.5.1 Catalent, Inc. Company Details
        7.5.2 Catalent, Inc. Business Overview
        7.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction
        7.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.5.5 Catalent, Inc. Recent Development
    7.6 Amatsigroup
        7.6.1 Amatsigroup Company Details
        7.6.2 Amatsigroup Business Overview
        7.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction
        7.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.6.5 Amatsigroup Recent Development
    7.7 WuXi AppTec Group
        7.7.1 WuXi AppTec Group Company Details
        7.7.2 WuXi AppTec Group Business Overview
        7.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction
        7.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.7.5 WuXi AppTec Group Recent Development
    7.8 Strides Pharma Science Limited
        7.8.1 Strides Pharma Science Limited Company Details
        7.8.2 Strides Pharma Science Limited Business Overview
        7.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction
        7.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.8.5 Strides Pharma Science Limited Recent Development
    7.9 Piramal Pharma Solutions
        7.9.1 Piramal Pharma Solutions Company Details
        7.9.2 Piramal Pharma Solutions Business Overview
        7.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction
        7.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.9.5 Piramal Pharma Solutions Recent Development
    7.10 Siegfried Ltd
        7.10.1 Siegfried Ltd Company Details
        7.10.2 Siegfried Ltd Business Overview
        7.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction
        7.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.10.5 Siegfried Ltd Recent Development
    7.11 Fareva Group
        7.11.1 Fareva Group Company Details
        7.11.2 Fareva Group Business Overview
        7.11.3 Fareva Group Pharmaceutical CDMO Services Introduction
        7.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.11.5 Fareva Group Recent Development
    7.12 FAMAR Health Care Services
        7.12.1 FAMAR Health Care Services Company Details
        7.12.2 FAMAR Health Care Services Business Overview
        7.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction
        7.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2017-2022)
        7.12.5 FAMAR Health Care Services Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Pharmaceutical CDMO Services Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Pharmaceutical CDMO Services Market Trends
    Table 3. Pharmaceutical CDMO Services Market Drivers
    Table 4. Pharmaceutical CDMO Services Market Challenges
    Table 5. Pharmaceutical CDMO Services Market Restraints
    Table 6. Global Pharmaceutical CDMO Services Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Pharmaceutical CDMO Services Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Pharmaceutical CDMO Services Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Pharmaceutical CDMO Services Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Pharmaceutical CDMO Services Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Pharmaceutical CDMO Services Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Pharmaceutical CDMO Services Revenue Share by Player, 2017-2022
    Table 13. Global Pharmaceutical CDMO Services Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Pharmaceutical CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CDMO Services as of 2021)
    Table 15. Top Players of Pharmaceutical CDMO Services in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Pharmaceutical CDMO Services Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Pharmaceutical CDMO Services Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Pharmaceutical CDMO Services Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Pharmaceutical CDMO Services Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Pharmaceutical CDMO Services Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Pharmaceutical CDMO Services Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Pharmaceutical CDMO Services Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Pharmaceutical CDMO Services Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Pharmaceutical CDMO Services Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Pharmaceutical CDMO Services Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Pharmaceutical CDMO Services Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Pharmaceutical CDMO Services Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Recipharm AB Company Details
    Table 31. Recipharm AB Business Overview
    Table 32. Recipharm AB Pharmaceutical CDMO Services Product
    Table 33. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 34. Recipharm AB Recent Development
    Table 35. AMRI Global Company Details
    Table 36. AMRI Global Business Overview
    Table 37. AMRI Global Pharmaceutical CDMO Services Product
    Table 38. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 39. AMRI Global Recent Development
    Table 40. Patheon N.V. Company Details
    Table 41. Patheon N.V. Business Overview
    Table 42. Patheon N.V. Pharmaceutical CDMO Services Product
    Table 43. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 44. Patheon N.V. Recent Development
    Table 45. Aenova Group Company Details
    Table 46. Aenova Group Business Overview
    Table 47. Aenova Group Pharmaceutical CDMO Services Product
    Table 48. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 49. Aenova Group Recent Development
    Table 50. Catalent, Inc. Company Details
    Table 51. Catalent, Inc. Business Overview
    Table 52. Catalent, Inc. Pharmaceutical CDMO Services Product
    Table 53. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 54. Catalent, Inc. Recent Development
    Table 55. Amatsigroup Company Details
    Table 56. Amatsigroup Business Overview
    Table 57. Amatsigroup Pharmaceutical CDMO Services Product
    Table 58. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 59. Amatsigroup Recent Development
    Table 60. WuXi AppTec Group Company Details
    Table 61. WuXi AppTec Group Business Overview
    Table 62. WuXi AppTec Group Pharmaceutical CDMO Services Product
    Table 63. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 64. WuXi AppTec Group Recent Development
    Table 65. Strides Pharma Science Limited Company Details
    Table 66. Strides Pharma Science Limited Business Overview
    Table 67. Strides Pharma Science Limited Pharmaceutical CDMO Services Product
    Table 68. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 69. Strides Pharma Science Limited Recent Development
    Table 70. Piramal Pharma Solutions Company Details
    Table 71. Piramal Pharma Solutions Business Overview
    Table 72. Piramal Pharma Solutions Pharmaceutical CDMO Services Product
    Table 73. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 74. Piramal Pharma Solutions Recent Development
    Table 75. Siegfried Ltd Company Details
    Table 76. Siegfried Ltd Business Overview
    Table 77. Siegfried Ltd Pharmaceutical CDMO Services Product
    Table 78. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 79. Siegfried Ltd Recent Development
    Table 80. Fareva Group Company Details
    Table 81. Fareva Group Business Overview
    Table 82. Fareva Group Pharmaceutical CDMO Services Product
    Table 83. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 84. Fareva Group Recent Development
    Table 85. FAMAR Health Care Services Company Details
    Table 86. FAMAR Health Care Services Business Overview
    Table 87. FAMAR Health Care Services Pharmaceutical CDMO Services Product
    Table 88. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2017-2022) & (US$ Million)
    Table 89. FAMAR Health Care Services Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pharmaceutical CDMO Services Product Picture
    Figure 2. Global Pharmaceutical CDMO Services Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Pharmaceutical CDMO Services Market Size 2017-2028 (US$ Million)
    Figure 4. United States Pharmaceutical CDMO Services Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Pharmaceutical CDMO Services Market Size 2017-2028 (US$ Million)
    Figure 6. United States Pharmaceutical CDMO Services Market Share in Global 2017-2028
    Figure 7. Pharmaceutical CDMO Services Report Years Considered
    Figure 8. Product Picture of Drug Substance Development and Manufacturing
    Figure 9. Product Picture of Specialized Services
    Figure 10. Product Picture of Lab-based Services
    Figure 11. Global Pharmaceutical CDMO Services Market Share by Type in 2022 & 2028
    Figure 12. Global Pharmaceutical CDMO Services Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Pharmaceutical CDMO Services Market Share by Type (2017-2028)
    Figure 14. United States Pharmaceutical CDMO Services Market Share by Type in 2022 & 2028
    Figure 15. United States Pharmaceutical CDMO Services Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Pharmaceutical CDMO Services Market Share by Type (2017-2028)
    Figure 17. Product Picture of Innovative Medicine
    Figure 18. Product Picture of Patented Drug
    Figure 19. Product Picture of Patent Expired Drug
    Figure 20. Global Pharmaceutical CDMO Services Market Share by Application in 2022 & 2028
    Figure 21. Global Pharmaceutical CDMO Services Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Pharmaceutical CDMO Services Market Share by Application (2017-2028)
    Figure 23. United States Pharmaceutical CDMO Services Market Share by Application in 2022 & 2028
    Figure 24. United States Pharmaceutical CDMO Services Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Pharmaceutical CDMO Services Market Share by Application (2017-2028)
    Figure 26. North America Pharmaceutical CDMO Services Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Pharmaceutical CDMO Services Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Pharmaceutical CDMO Services Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Pharmaceutical CDMO Services Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Pharmaceutical CDMO Services Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. U.A.E Pharmaceutical CDMO Services Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 55. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 56. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 57. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 58. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 59. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 60. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 61. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 62. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 63. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 64. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 65. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Recipharm AB
AMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services
Frequently Asked Questions
Pharmaceutical CDMO Services report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmaceutical CDMO Services report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmaceutical CDMO Services report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports